(PharmaNewsWire.Com, February 12, 2020 ) The report "Microcrystalline Cellulose (MCC) Market by Application (Food & Beverage, Pharmaceutical, Cosmetics & Personal Care), Raw Material Source (Wood-based, Non-wood - based), and Region (North America, Europe, APAC, RoW) - Global Forecasts to 2024" The MCC market is projected to grow from USD 938 million in 2019 to USD 1,315 million by 2024, at a CAGR of 7.0%, between 2019 and 2024. The growth of the MCC market is primarily triggered by the increasing demand for processed food and growing production of pharmaceuticals and increasing cosmetic applications.
The pharmaceutical application segment is projected to register the highest CAGR in terms of both value and volume during the forecast period.
The growth of the global MCC market is dependent on the growth of the pharmaceutical excipient market. MCC acts as a filler, binder, disintegrant, suspending agent, lubricant, and glidant in pharmaceutical manufacturing. It is used in the direct compression method as it reduces the production cost. MCC is a vital component that is used in every form of oral dosage, which includes pellets, capsules, tablets, and sachets.
The wood-based segment is projected to account for the major market share during the forecast period.
Wood is the traditional choice of raw material for MCC production. Commercially produced wood pulp used to manufacture MCC is obtained from sources, such as softwood woods (gymnosperms) and hardwood (dicotyledons). Gymnosperms include fir trees, spruce trees, pine trees, conifers, and cycads. The chemical property of MCC produced from different wood sources varies because of the difference in the composition of alpha-cellulose in different kinds of woods available.
Browse in-depth TOC on "Microcrystalline Cellulose (MCC) Market” 79 - Market Data Tables 32 - Figures 109 - Pages
Europe is estimated to be the largest market for microcrystalline cellulose in 2019, in terms of value.
Europe is the largest MCC market, in terms of value, in 2019. The European region is segmented into Germany, France, the UK, Switzerland, Italy, and Spain. The overall market growth of the region is driven mainly by the increasing investments in drug development and the continuous efforts of pharmaceutical companies to offer superior-quality products. In addition, the economic recovery and the increase in employment rate are the growth factors for the processed food industry in the region, which, in turn, supports the growth of the MCC market in the food & beverage application.
Key players operating in the MCC market are DuPont (US), Asahi Kasei Chemicals Corporation (Japan), Rayonier Advanced Materials (US), Roquette (France), and DFE Pharma GmbH & Co.KG (Germany), among others.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
